FTO exerts oncogenic effects on various types of cancer cells, promoting tumor cell growth by activating survival and cell-cycle signaling, such as PI3K/Akt/mTOR pathway, MYC, β-catenin, and CEBPA [10, 57]. The gene discussed is CEBPA; the disease is cancer.